Model DetailsUterus - Cervix tumor
Model Name |
Uterus - Cervix tumor | Strain |
CD-1 |
Tumor Inducing Agent(s) |
Hormone : diethylstilbestrol (DES) |
Tumor Synonyms |
cervical tumor • tumor of the cervix |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Uterus - Cervix | Female |
0% (0 of 15 mice) |
12 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 3 mice) |
13 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
50% (1 of 2 mice) |
15 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 1 mice) |
17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
4.8% (1 of 21 mice) |
12-17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 4 mice) |
12 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 9 mice) |
13 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 1 mice) |
14 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 1 mice) |
16 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
25% (1 of 4 mice) |
18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
5.3% (1 of 19 mice) |
12-18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 3 mice) |
13 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 1 mice) |
16 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 7 mice) |
17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 6 mice) |
18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 17 mice) |
13-18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
33% (1 of 3 mice) |
13 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 1 mice) |
15 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 1 mice) |
16 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 6 mice) |
17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 11 mice) |
18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
4.5% (1 of 22 mice) |
13-18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 6 mice) |
12 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 12 mice) |
13 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 2 mice) |
16 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 3 mice) |
17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 12 mice) |
18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 35 mice) |
12-18 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 8 mice) |
12 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
10% (1 of 10 mice) |
13 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 1 mice) |
14 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
0% (0 of 1 mice) |
17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus - Cervix | Female |
5.0% (1 of 20 mice) |
12-17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |